Daniel Chancellor
Therapeutic Area Director
+11 year(s) experience
He stays abreast of market developments, generating and curating data sources, and distilling these into reports that enable clients to gain a competitive edge.
Since joining Pharma Intelligence in 2010, Daniel has tracked and forecast all the leading neurology, psychiatry, and pain drug markets. He is particularly interested in the shifting landscape of the multiple sclerosis market well as the implications of trial failures – alongside the successes in Alzheimer's disease R&D.
He has helped expand research and insight on rare diseases , including established orphan drug markets as well as as emerging opportunities. He also attends international medical conferences and enjoys collaborating with colleagues at Scrip.
Daniel has a First Class degree in Natural Sciences from the University of Bath.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
Joining the international regulatory collaboration could become a key route for the UK to remain an early and priority market for global launches after the end of the Brexit transition period, says the industry group, BIA.
Topic Pharma-Brexit brexit
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
The stakes are extremely high for companies called before EU or US regulators and scientific experts to answer queries about their new drug applications at the later stages of the review process. How they perform is critical. Consultant Kate Dion has a raft of helpful tips for companies facing this daunting situation. Neena Brizmohun reports.
Topic drug-approval
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
Novartis, having now submitted its CAR-T therapy CTL019 to the European Medicines Agency for approval.
Topic drug-review
Pink Sheet: 世界の薬事規制と...
07 Apr 2016
Medtech Insight: 世界の...
21 Mar 2016
Pink Sheet: 世界の薬事規制と...
18 Mar 2016
Medtech Insight: 世界の...
17 Mar 2016
Pink Sheet: 世界の薬事規制と...
14 Mar 2016
Pink Sheet: 世界の薬事規制と...
09 Mar 2016
Pink Sheet: 世界の薬事規制と...
19 Feb 2016
Medtech Insight: 世界の...
17 Feb 2016
Medtech Insight: 世界の...
15 Feb 2016
Medtech Insight: 世界の...
12 Feb 2016
Medtech Insight: 世界の...
10 Feb 2016
Pink Sheet: 世界の薬事規制と...
03 Feb 2016
Pink Sheet: 世界の薬事規制と...
29 Jan 2016
Pink Sheet: 世界の薬事規制と...
05 Jan 2016
Medtech Insight: 世界の...
27 Nov 2015